Director Security & Investigations |
Basel (City) |
Switzerland |
Legal |
Corporate |
Legal & Intellectual Property & Compl. |
Sep 09, 2024 |
IM Legal Head MEA Cluster |
Dubai |
Utd.Arab Emir. |
Legal |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Sep 09, 2024 |
Associate Director Risk, Policy & Controls |
Dublin (Novartis Corporate Center (NOCC)) |
Ireland |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
Sep 04, 2024 |
Associate Director, Data Privacy, Digital & AI |
East Hanover |
USA |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
Sep 04, 2024 |
Country ERC Head, India |
Mumbai (Office) |
India |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Sep 03, 2024 |
Head, Legal Business Services |
Hyderabad (Office) |
India |
Operations |
CTS |
Legal & Intellectual Property & Compl. |
Sep 03, 2024 |
Associate Director ERC Risk&Operations, Corporate Functions |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
Aug 29, 2024 |
Ethics, Risk & Compliance Manager |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Aug 22, 2024 |
Juriste CDD H/F |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
Legal |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Aug 08, 2024 |
Patent Paralegal |
Cambridge (USA) |
USA |
Legal |
Pharma Research |
Legal & Intellectual Property & Compl. |
Jul 19, 2024 |
Patent Attorney II |
Cambridge (USA) |
USA |
Legal |
Pharma Research |
Legal & Intellectual Property & Compl. |
Jul 19, 2024 |
Sr Manager/Manager-Monitoring |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Jul 18, 2024 |
Head DPDAI China |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Jul 04, 2024 |
Senior Legal Counsel |
Shanghai (Shanghai) |
China |
Legal |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Jul 02, 2024 |
Associate Director Compliance Review and Remediation |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
Jun 19, 2024 |